Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccine Development
At Least 400 Vaccine Products Are In The Works
April 11th, 2001
Despite recent reports of the potential dangers associated with certain pediatric vaccines, controversies surrounding clinical trial procedures, and conflicting patent positions, the pipeline for vaccine products is more robust than ever. According to a new study from Theta Reports, New York, more than 15 new immunotherapy medicines have come to market in the past two years and at least 25 products are in late stage clinical trials. Furthermore, at least 400 vaccine products are in various earlier stages of development. Therapeutic vaccines, the category that represents the vast majority of early-stage products, include antibody, gene, and...
Source: Vaccine Weekly (2001-04-11)
|
